These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Preliminary characterization of a structural defect in homozygous sickled cell alpha spectrin demonstrated by a rabbit autoantibody.
    Author: Monteiro CA, Gibson X, Shartava A, Goodman SR.
    Journal: Am J Hematol; 1998 Jul; 58(3):200-5. PubMed ID: 9662271.
    Abstract:
    We have identified a rabbit autoantibody that strongly reacts with the core membrane skeleton of control red blood cells, and does not react with low- or high-density sickle cell core skeletons upon indirect immunofluorescence. Western blot analysis of red blood cell membrane proteins, utilizing this autoantibody, indicated no reactivity to any protein when SDS-PAGE was conducted in the presence of the reducing agent, dithiothreitol. However when SDS-PAGE was performed on control red blood cell membrane proteins separated in the absence of dithiothreitol, the autoantibody specifically reacted with a high molecular weight polypeptide (apparent Mr approximately equal to 310 kD) representing a DTT sensitive form of control alpha spectrin, which we refer to as alpha' spectrin. There was no staining of high density or low density sickle cell alpha or alpha' spectrin. This autoantibody should be an excellent tool for the fine mapping of structural change(s) in control vs. sickle cell alpha spectrin, and determination of whether the structural alteration effects spectrin dimer-tetramer interconversion and/or the spectrin-actin interaction. The modification in alpha spectrin, detected by this antibody, is very specific for homozygous SS alpha spectrin because sickle cell beta+ thalassemic alpha spectrin and sickle cell trait alpha spectrin react intensely with the autoantibody.
    [Abstract] [Full Text] [Related] [New Search]